Human growth hormone increases apo(a) expression in transgenic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2439-2447

  Tao, Ruixian ^d   Acquati, Francesco ^a   Marcovina, Santica M ^b   Hobbs, Helen H ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NONE

Author keywords

Apo(a); Growth hormone; Insulin like growth factor 1

Indexed keywords

APOLIPOPROTEIN A; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CASTRATION; DOSE RESPONSE; GENETIC TRANSCRIPTION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0032857365     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2439     Document Type: Article

References (45)

1. Utermann G. Lipoprotein(a). In: Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York; 1995: 1887-1912.
2. Boerwinkle E, Xiong W, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci U S A. 1989;86:212-216.
3. Krempler F, Kostner GM, Bolzano K. Turnover of lipoprotein (a) in man. J Clin Invest. 1980;65:1483-1490.
4. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation: Complications for apolipoprotein synthesis. J Clin Invest. 1989;83:137-142.
5. Makino K, Abe A, Maeda S, Noma A, Kawade M, Takenaka O. Lipoprotein(a) in nonhuman primates: Presence and characteristics of Lp(a) immunoreactive materials using anti-human Lp(a) serum. Atherosclerosis. 1989;78:81-85.
6. Lawn RM, Boonmark NW, Schwartz K, Lindahl KM, Wade DP, Byrne CD, Fong KJ, Meer K, Pathy L. The recurring evolution of lipoprotein(a). J Biol Chem. 1995;270:24004-24009.
7. Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem. 1992;267:24369-24374.
8. Frazer KA, Narla G, Zhang JL, Rubin EM. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet. 1995;9:424-431.
9. Zysow BR, Kauser K, Lawn RM, Rubanyi GM. Effects of estrus cycle, ovariectomy, and treatment with estrogen, tamoxifen, and progesterone on apolipoprotein(a) gene expression. Arterioscler Thromb Vasc Biol. 1997;17:1741-1745.
10. Eden S. Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinology. 1979;105:555-560.
11. Tannenbaum GS, Martin JB. Evidence for an endogenous circadian rhythm governing growth hormone secretion in the rat. Endocrinology. 1976;98:562-570.
12. MacLeod JN, Pampori NA, Shapiro BH. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol. 1991;131:395-399.
13. Gustafsson J-A, Mode A, Norstedt G, Skett P. Sex-steroid induced changes in hepatic enzymes. Ann Rev Physiol. 1983;45:51-60.
14. Waxman DJ, Pampori NA, Ram PA, Agrawal AK, Shapiro BH. Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc Natl Acad Sci U S A. 1991;88:6868-6872.
15. Lam KSL, Pang RWC, Janus ED, Kung AWC, Wang CLC. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly. Artherosclerosis. 1993;104:183-188.
16. Wildbrett J, Hanefeld M, Fucker K, Pinzer T, Bergmann S, Siegert G, Breidert M. Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like growth factor I. Exp Clin Endocrinol Diabetes. 1997;105:331-335.
17. Laron Z, Wang XL. Growth hormone, lipoprotein(a) and cardiovascular disease. Eur Heart J. 1998;19:204-206.
18. Zapf J, Froesch ER, Humbel RE. The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul. 1981;19: 257-309.
19. Olivercrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B. Hormonal regulation of serum lipoprotein(a) levels. Arterioscler Thromb Vasc Biol. 1995;15:847-849.
20. Bianda T, Schmid C. Effects of short-term treatment with insulin-like growth factor-I and growth hormone and serum lipoprotein(a) in growth hormone-deficient adults. Eur J Endocrinol. 1998;138:189-190.
21. Laron Z, Wang XL, Klinger B, Silbergeld A, Wilcken DEL. Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome. Metabolism. 1996;10: 1263-1266.
22. Oscarsson J, Lundstam UK, Gustafsson B, Wilton P, Eden S, Wiklund O. Recombinant human insulin-like growth faclor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol. 1995; 42:673-676.
23. Acquati F, Hammer R, Ercoli B, et al. Transgenic mice expressing a human apolipoprotein(a) allele. J Lipid Res. 1998. In press.
24. Landschulz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest. 1996;98: 984-995.
25. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH. Apo(a) kringle 4-containing fragments in human urine: Relationship to plasma levels of lipoprotein(a). J Clin Invest. 1996;97:858-864.
26. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41:246-255.
27. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619-627.
28. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci U S A. 1986;83:9343-9347.
29. Chen W-J, Goldstein JL, Brown MS. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J Biol Chem. 1990;265: 3116-3123.
30. Shimano H, Shimonur L, Hammer R, Herz J, Goldstein JL, Brown MS, Horton JD. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest. 1997;100:2115-2124.
31. Lembo G, Rockman HA, Hunter JJ, Steinmetz H, Kock WJ, Ma L, Prinz MP, Ross J Jr, Chein KR, Powell-Braxton L. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest. 1996;98:2648-2655.
32. Edén S, Wiklund O, Oscarsson J, Rosén T, Bengtsson B-A. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb. 1993;13:296-301.
33. Waxman DJ, Ram PA, Park S-H, Choi HK. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, stat 5-related DNA binding protein. J Biol Chem. 1995; 270:13262-13270.
34. Norstedt G, Mode A, Eneroth P, Gustafsson J-A. Induction of prolactin receptors following administration of growth hormone. Endocrinology. 1981;108:1855-1866.
35. Mooser V, Hobbs HH. Lipoprotein(a) and growth hormone: is the puzzle solved? Eur J Endocrinol. 1997;137:450-452.
36. Nolte W, Radisch C, Armstrong VW, Hufner M, von zur Muhlen A. The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: Results of a double-blinds and placebo-controlled trial. Eur J Endocrinol. 1997; 137:459-466.
37. Johannsson G, Oscarsson J, Rosen T, Wiklund O, Olsson G, Wilhelmson L, Bengtsson BA. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Arterioscler Thromb Vasc Biol. 1995;15:2142-2150.
38. Oscarsson J, Ottosson M, Wiklund O, Marin P, Vikman-Adolfsson K, Bjorntorp P, Eden S. Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men. Clin Endocrinol. 1994; 41:109-116.
39. Sandstedt J, Tornell J, Norjavaara E, Isaksson P. Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. Endocrinology. 1996;137:3368-3374.
40. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation. 1993;87:1135-1141.
41. Ho KKY, O'Sullivan AJ, Weissberger AJ, Kelly JJ. Sex steroid regulation of growth hormone secretion and action. Horm Res. 1996;45:67-73.
42. Kim CJ, Jang HC, Cho DH, Min YK. Effects of hormone replacement therapy on lipoprotein(a) and lipids in posimenopausal women. Arterioscler Thromb. 1994;14:275-281.
43. Palmiter RD, Brinster RL, Hammer RE, Trambauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature. 1982;300:611-615.
44. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997;94:7239-7244.
45. Rouy D, Duverger N, Lin SD, Emmanuel F, Houdebine LM, Denefle P, Viglietta C, Gong E, Rubin EM, Hughes SD. Apolipoprotein(a) yeast artificial chromosome transgenic rabbits: Lipoprotein(a) assembly with human and rabbit apolipoprotein B. J Biol Chem. 1998;273:1249-1251.